NCT06457776 Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
| NCT ID | NCT06457776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Catholic University of the Sacred Heart |
| Condition | Osteonecrosis of the Jaw |
| Study Type | OBSERVATIONAL |
| Enrollment | 126 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 126 participants in total. It began in 2021-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.
Eligibility Criteria
Inclusion Criteria: * Patients with specific prescription to initiate therapy with antiresorptive drugs Exclusion Criteria: * Previous Head and Neck Radiotherapy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06457776 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteonecrosis of the Jaw. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457776 currently recruiting?
Yes, NCT06457776 is actively recruiting participants. Contact the research team at carlo.lajolo@unicatt.it for enrollment information.
Where is the NCT06457776 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06457776 clinical trial?
NCT06457776 is sponsored by Catholic University of the Sacred Heart. The trial plans to enroll 126 participants.